Back to Journals » Cancer Management and Research » Volume 14

Review

Update on Lorlatinib: Role in Reducing the Risk of Disease Progression in ALK-Positive NSCLC

       
Total article views   HTML views PDF downloads Totals
9,555 Dovepress* 7,258+ 374 7,632
PubMed Central* 2,297 486 2,783
Totals 9,555 860 10,415
*Since 26 February 2022
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 1 2 3

View citations on PubMed and Google Scholar